Raymond James Downgrades Mednax (MD) to Market Perform
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Raymond James downgraded Mednax (NYSE: MD) from Outperform to Market Perform.
Shares of Mednax closed at $65.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Downgrades Fortress Transportation (FTAI) to Outperform
- UPDATE: Wells Fargo Downgrades Goldman Sachs BDC, Inc. (GSBD) to Market Perform Citing Valution
- Credit Suisse Downgrades Kohl's (KSS) to Underperform
Create E-mail Alert Related CategoriesDowngrades
Related EntitiesRaymond James
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!